OncoPharm

John Bossaer
undefined
Feb 3, 2022 • 22min

GI Cancer Updates & Tebentafusp

We quickly cover some of the ASCO GI highlights from a couple weeks ago and delve deep into the role of ICIs in metastatic esophageal caner. Finally, does tebentafusp's approval tell us anything about the future intersection of immunotherapy and precision medicine?
undefined
Jan 27, 2022 • 57min

Precision Medicine Demystified

Dr. Howard McLeod joins the pod to talk Precision Medicine and the role pharmacists can play using pharmacogenomics and tumor genomics in cancer care. https://www.drhowardmcleod.com
undefined
Jan 20, 2022 • 19min

New Hallmarks Of Cancers & LenPembro For Endometrial Cancer

Topic covered include the latest updates to the seminal Hallmarks of Cancer work, adjuvant pembrolizumab for stage IIB/IIC melanoma, a prospective study of UGT1A1 testing, and Keynote-775. Hallmarks of Cancer: New Dimensions. https://cancerdiscovery.aacrjournals.org/content/12/1/31 UGT1A1 Genotype-guided dosing of irinotecan: https://doi.org/10.1016/j.ejca.2021.12.009 Keynote-775: https://www.nejm.org/doi/full/10.1056/NEJMoa2108330
undefined
Jan 13, 2022 • 27min

Carfilzomib

Dive into the world of carfilzomib, a key player in the fight against multiple myeloma. Discover its unique mechanism of action and how it stacks up against bortezomib. The discussion highlights important dosing strategies and potential side effects. Recent studies are also examined, aimed at improving patient outcomes and clinical practices. It's an insightful exploration of innovative treatments in oncology!
undefined
Jan 6, 2022 • 21min

So, You Want to Work (from home) as a Specialty Pharmacist

We're joined by Dr. Ryan McDade to hear about working as a Clinical Pharmacy Lead for Humana Specialty Pharmacy.
undefined
Dec 23, 2021 • 10min

Drugs of 2021: Keep, Return Or Re-gift?

Happy Holidays!
undefined
Dec 16, 2021 • 28min

ASH21 The More Things Change...

Reviewing some big news from ASH21 concerning DLBCL that has us asking, "the more the change, the more R-CHOP remains the same?" Also, we talk CAR-T (ZUMA-7 & BELINDA), sotorasib, a possible way to predict poor response to ICI (HLA-A*03), and Evusheld as a possible way to protect those patients destined to a poor vaccine response from COVID.
undefined
Dec 9, 2021 • 21min

So, You Want to be a Pediatric Oncology Pharmacist

The 2nd episode in our Career Paths series features Dr. Morgan Randolph. She gives great insight into her role as pediatric oncology pharmacist and the choice between a PGY2 in Pediatrics or Oncology for those considering that decision.
undefined
Dec 2, 2021 • 20min

Dasatinib Dosing & DREAMseq

Lots of updates to discuss from dasatinib dosing to ICI/TKI sequencing in BRAF-mutated metastatic melanoma to adjuvant chemo in node (+) breast cancer to some FDA approval updates.
undefined
Nov 18, 2021 • 14min

Sun's Out, T Cells Out

Discussing one of the more intriguing studies of the year looking at whether metastatic melanoma survival is effected by what time of day immunotherapy is administered. Link: https://doi.org/10.1016/S1470-2045(21)00546-5

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app